Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Renal Cell

Explore clinical trials studying Carcinoma, Renal Cell. Study availability and eligibility vary by location and protocol.

1,363 public trials 252 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Renal Cell trial results

Completed

Non-Interventional Study Of Indian Patients With Advanced Renal Cell Cancer Receiving Therapy With Sutent

NCT00836745

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +18 more
Locations
  • Pfizer Investigational Site Jaipur, India
  • Pfizer Investigational Site Bangalore, Karnataka, India
  • Pfizer Investigational Site Mumbai, Maharashtra, India
  • Pfizer Investigational Site New Delhi, National Capital Territory of Delhi, India
View Trial Details
Completed

Interferon Alfa With or Without Interleukin-2 and Fluorouracil in Treating Patients With Advanced Metastatic Kidney Cancer

NCT00053820

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • Onze Lieve Vrouw Ziekenhuis Aalst Aalst, Belgium
  • Institut Jules Bordet Brussels, Belgium
  • Academisch Ziekenhuis der Vrije Universiteit Brussel Brussels, Belgium
  • Universitair Ziekenhuis Antwerpen Edegem, Belgium
View Trial Details
Completed

Temsirolimus Versus Sorafenib As Second-Line Therapy In Patients With Advanced RCC Who Have Failed First-Line Sunitinib

NCT00474786

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +18 more
Locations
  • Pfizer Investigational Site Duarte, California, United States
  • Pfizer Investigational Site La Jolla, California, United States
  • Pfizer Investigational Site La Jolla, California, United States
  • Pfizer Investigational Site Los Angeles, California, United States
View all 128 locations
View Trial Details
Completed

Community Oncology Setting Disease Outcomes of Sorafenib (Nexavar) Use in Advanced Renal Cell Carcinoma

NCT00876382

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • Northeast Arkansas Clinic Jonesboro, Arkansas, United States
  • Gulfcoast Oncology Associates St. Petersburg, Florida, United States
  • Medical Oncology Associates of Augusta Augusta, Georgia, United States
  • Consultants in Blood Disorders and Cancer Louisville, Kentucky, United States
View Trial Details
Completed

A Drug-Drug Interaction Study of the Effects of XL184 (Cabozantinib) on Rosiglitazone in Subjects With Solid Tumors

NCT01100619

Conditions
Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +25 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Montefiore Medical Center The Bronx, New York, United States
  • Hospital of the University of Pennsylvania Philadelphia, Pennsylvania, United States
View Trial Details
Completed

PS-341 in Treating Patients With Metastatic Kidney Cancer

NCT00025376

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • University of Chicago Cancer Research Center Chicago, Illinois, United States
  • Louis A. Weiss Memorial Hospital Chicago, Illinois, United States
  • Cancer Care Specialists of Central Illinois, S.C. Decatur, Illinois, United States
  • Ingalls Memorial Hospital Harvey, Illinois, United States
View Trial Details

Related conditions